Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LETROZOLE 2.5 MG TABLET

LETROZOLE
$0.1511per EA

Strength

2.5 mg/1

Manufacturer

AvPAK

NDC

50268047615

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LETROZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA200161

On Market Since

10/2/2019

Pharmacological Classes

Aromatase Inhibitor
Aromatase Inhibitors

Price History

1W

0.0%

1M

+3.9%

3M

+7.4%

6M

+13.9%

1Y

+5.8%

3Y

+35.9%

5Y

+5.0%

All

+14.0%

Generic Alternatives

1 alternative • Same active ingredient

LETROZOLE 2.5 MG TABLET
Generic
51991075910•Breckenridge Pharmaceutical Inc.
$0.1511

Related Drugs

Same classification

LETROZOLE 2.5 MG TABLET
Generic
69117000401•Yiling Pharmaceutical Inc.
$0.1203
per EA
ANASTROZOLE 1 MG TABLET
Generic
68382020910•Zydus Pharmaceuticals (USA) Inc.
$0.1366
per EA
ANASTROZOLE 1 MG TABLET
Generic
00093753656•Teva Pharmaceuticals USA Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
16729003510•Accord Healthcare Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
16729003515•Accord Healthcare Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
16729003516•Accord Healthcare Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
23155085703•Avet Pharmaceuticals Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
23155085705•Avet Pharmaceuticals Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
23155085709•Avet Pharmaceuticals Inc.
$0.1376
per EA
ANASTROZOLE 1 MG TABLET
Generic
50268007515•AvPAK
$0.1376
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy